Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001362584 | SCV001558611 | uncertain significance | Progressive sclerosing poliodystrophy | 2020-07-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The proline amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This sequence change replaces serine with proline at codon 63 of the POLG protein (p.Ser63Pro). The serine residue is weakly conserved and there is a moderate physicochemical difference between serine and proline. This variant is present in population databases (rs781006710, ExAC 0.002%). This variant has not been reported in the literature in individuals with POLG-related conditions. |
Mayo Clinic Laboratories, |
RCV001509501 | SCV001716247 | uncertain significance | not provided | 2019-10-20 | criteria provided, single submitter | clinical testing |